Latest

Learn how antibiotic-resistant UTI testing identifies ESBL, CRE, resistance genes, and antibiotic susceptibility, and how culture results guide treatment and follow-up.

Antibiotic-Resistant UTI Test: ESBL, CRE, Resistance Markers, and Culture Meaning

Learn what asymptomatic bacteriuria means, how a positive urine culture without UTI symptoms is interpreted, and when screening, treatment, or follow-up matters.

Asymptomatic Bacteriuria Test: Positive Culture Without Symptoms and When It Matters

Learn how bacteria in urine are interpreted using urinalysis, culture, colony count, symptoms, and sample quality, including when contamination or follow-up testing matters.

Bacteria in Urine Test: UTI, Contamination, Colony Count, and Culture Follow-Up

Learn how a catheter urine culture helps diagnose catheter-associated UTI, how samples are collected, and what colony counts, pyuria, resistance, and positive results mean.

Catheter Urine Culture Test: Catheter-Associated UTI and Culture Meaning

Learn how a chlamydia and gonorrhea urine NAAT works, how to collect first-catch urine, what positive or negative results mean, and when follow-up testing is needed.

Chlamydia and Gonorrhea Urine NAAT Test: STI Screening, Positive Result, and Meaning

Learn how to collect a clean-catch urine culture, reduce contamination, handle the sample correctly, and understand mixed flora, colony counts, repeat testing, and accurate results.

Clean-Catch Urine Culture Test: Sample Collection, Contamination, and Accurate Results

Diagnostics

Home Diagnostics Page 24

Learn how the TTF-1 IHC test helps identify lung adenocarcinoma, what positive or negative nuclear staining means, and why other markers are needed.

TTF-1 IHC Test for Lung Cancer: Tumor Origin, Adenocarcinoma Marker, and...

Learn what a lung cancer TMB test measures, how mutations per megabase are calculated, what TMB-high means, and how the score fits with PD-L1, NGS, and immunotherapy decisions.

Tumor Mutational Burden (TMB) Test for Lung Cancer: Mutation Load, Genomic...

Learn how blood-based multi-cancer early detection tests find cancer signals, what positive and negative results mean, and what follow-up may involve.

Blood-Based Multi-Cancer Early Detection Test: Cancer Signals, Screening, and Follow-Up

CancerSEEK combines tumor DNA mutations and protein markers for multi-cancer detection. Learn what research shows, how results are interpreted, and why follow-up matters.

CancerSEEK Test: Multi-Cancer Blood Test, Tumor Markers, and Early Detection Research

Understand how cell-free DNA cancer tests detect tumor DNA, mutations, and blood-based genomic signals, plus what positive, negative, and inconclusive results mean.

Cell-Free DNA Cancer Test: Tumor DNA in Blood, Mutation Detection, and...

Learn how circulating tumor cell tests detect tumor cells in blood, what CTC counts can mean for prognosis, and how CTC testing compares with ctDNA liquid biopsy.

Circulating Tumor Cell (CTC) Test: Tumor Cells in Blood, Cancer Monitoring,...

Learn what high circulating tumor cell counts mean, including common CTC thresholds, prognosis, tumor-burden limits, treatment trends, and result interpretation.

Circulating Tumor Cell Count Test: High Levels, Tumor Cell Burden, and...

Learn how a ctDNA test detects tumor DNA in blood, what mutations and MRD results mean, how ctDNA tracks treatment, and how it relates to recurrence risk.

Circulating Tumor DNA (ctDNA) Test: Cancer Monitoring, Mutations, MRD, and Recurrence...

Learn what a ctDNA MRD test means, how tumor-informed and tumor-naive testing differ, and how positive or negative results relate to cancer recurrence risk.

ctDNA Minimal Residual Disease (MRD) Test: Recurrence Risk, Tumor DNA Monitoring,...

Learn how a ctDNA mutation panel finds tumor mutations and resistance markers in blood, what actionable and negative results mean, and when tissue testing is still needed.

ctDNA Mutation Panel: Tumor Mutations, Blood-Based Genomic Testing, and Resistance Markers

$Learn what a ctDNA tumor fraction test measures, how blood DNA percentage is calculated, what low or high results may mean, and why assay limits matter.$

ctDNA Tumor Fraction Test: Cancer Burden, Blood DNA Percentage, and Result...

EGFR T790M Liquid Biopsy Test: Lung Cancer Resistance Mutation and ctDNA...

Learn what an ESR1 liquid biopsy detects, how positive and negative ctDNA results are interpreted, and how emerging ESR1 mutations can guide advanced breast cancer therapy.

ESR1 Liquid Biopsy Test: Breast Cancer Hormone Resistance Marker and ctDNA...

Learn how exosome cancer tests analyze tumor RNA, proteins, DNA, and extracellular vesicles, what abnormal results may mean, and why most uses remain under research.

Exosome Cancer Test: Tumor RNA, Blood Biomarkers, and Diagnostic Research

Learn how FoundationOne Liquid CDx analyzes ctDNA for cancer mutations, how to read the genomic report, what companion-diagnostic findings mean, and why tissue testing may still be needed.

FoundationOne Liquid CDx Test: ctDNA, Cancer Genomics, Mutation Report, and Companion...

Learn how fragmentomics cancer blood tests analyze cell-free DNA length, ends, and genome-wide patterns, what classifier results mean, and why early-detection use still requires prospective validation.

Fragmentomics Cancer Blood Test: Cell-Free DNA Patterns and Early Detection Research

1...232425...137 Page 24 of 137